Omalizumab treats multi-food allergy better than oral immunotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-May-2025 16:09 ET (28-May-2025 20:09 GMT/UTC)
The high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial explained the superiority of omalizumab.